Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Russo

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Rheumatology|March 27, 2009
Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximabMaría M Katsicas, Ricardo A G Russo
Medicina|June 14, 2016
[Autoinflammatory diseases]Ricardo A G Russo, María M Katsicas
Frontiers in Pediatrics|October 20, 2018
Takayasu ArteritisRicardo A G Russo, María M Katsicas
The Journal of Rheumatology|May 14, 2009
Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agentsRicardo A G Russo, María M Katsicas
Pediatric Rheumatology Online Journal|June 7, 2007
Clinical characteristics of children with Juvenile Systemic Sclerosis: follow-up of 23 patients in a single tertiary centerRicardo A G Russo, María M Katsicas
Clinical and Experimental Rheumatology|August 13, 2005
Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanerceptM M Katsicas, R A G Russo
The Journal of Rheumatology|April 10, 2008
Global damage in systemic juvenile idiopathic arthritis: preliminary early predictorsRicardo A G Russo, María M Katsicas
The Journal of Rheumatology|January 17, 2013
Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcomeRicardo A G Russo, María M Katsicas
Rheumatology (Oxford, England)|May 17, 2014
Monogenic autoinflammatory diseasesRicardo A G Russo, Paul A Brogan
Clinical and Experimental Rheumatology|November 5, 2002
Etanercept in systemic juvenile idiopathic arthritisR A G Russo, M M Katsicas, M Zelazko
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Rheumatology|March 27, 2009
Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximabMaría M Katsicas, Ricardo A G Russo
Medicina|June 14, 2016
[Autoinflammatory diseases]Ricardo A G Russo, María M Katsicas
Frontiers in Pediatrics|October 20, 2018
Takayasu ArteritisRicardo A G Russo, María M Katsicas
The Journal of Rheumatology|May 14, 2009
Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agentsRicardo A G Russo, María M Katsicas
Pediatric Rheumatology Online Journal|June 7, 2007
Clinical characteristics of children with Juvenile Systemic Sclerosis: follow-up of 23 patients in a single tertiary centerRicardo A G Russo, María M Katsicas
Clinical and Experimental Rheumatology|August 13, 2005
Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanerceptM M Katsicas, R A G Russo
The Journal of Rheumatology|April 10, 2008
Global damage in systemic juvenile idiopathic arthritis: preliminary early predictorsRicardo A G Russo, María M Katsicas
The Journal of Rheumatology|January 17, 2013
Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcomeRicardo A G Russo, María M Katsicas
Rheumatology (Oxford, England)|May 17, 2014
Monogenic autoinflammatory diseasesRicardo A G Russo, Paul A Brogan
Clinical and Experimental Rheumatology|November 5, 2002
Etanercept in systemic juvenile idiopathic arthritisR A G Russo, M M Katsicas, M Zelazko
Pageof 2